Algorithmic telehealth assessments structurally cannot identify complex eating disorder presentations because atypical anorexia and non-purging bulimia require clinical specialist judgment that online questionnaires lack
DePaul JHLI analysis identifies diagnostic gap: algorithmic assessments miss eating disorder subtypes that present in larger bodies or without obvious purging behaviors
Claim
DePaul Journal of Health Law and Innovation analysis (April 2026) argues that telehealth's algorithmic assessments cannot capture the psychological complexity needed to identify eating disorder risk. Specific diagnostic gap: atypical anorexia nervosa (presenting in larger body) or non-purging bulimia nervosa may be misdiagnosed as binge eating disorder. These presentations require clinical specialist judgment because they lack the visible markers (low BMI, purging behaviors) that structured questionnaires can detect. The mechanism is architectural: online assessments use standardized questions optimized for high-volume processing, but complex eating disorder presentations require contextual clinical judgment about psychological relationship to food, body image distortion, and compensatory behaviors that don't fit questionnaire categories. This creates a systematic screening failure for the exact population most likely to seek GLP-1s through telehealth: individuals in larger bodies with undiagnosed restrictive or compensatory eating patterns. The clinical risk: GLP-1s' delayed gastric emptying can trigger or worsen purging behaviors, and rapid appetite suppression can trigger or worsen restrictive behaviors—but these risks are invisible to algorithmic assessment.
Sources
1- 2026 05 12 fda glp1 telehealth warning letters screening gap
inbox/queue/2026-05-12-fda-glp1-telehealth-warning-letters-screening-gap.md
Reviews
1# Leo's Review ## 1. Schema All three new claims have complete frontmatter with type, domain, confidence, source, created, description, and title fields; the four enrichments correctly add evidence to existing claims without modifying their frontmatter; entity files (beluga-health.md, depaul-jhli.md, md-integrations.md, openloop.md, telegra.md) and the source file (inbox/queue/2026-05-12-fda-glp1-telehealth-warning-letters-screening-gap.md) are not shown in the diff but are referenced and would follow their respective schemas. ## 2. Duplicate/redundancy The new claim "algorithmic-telehealth-assessments-cannot-detect-complex-eating-disorder-presentations.md" provides mechanistic detail (architectural limitations of questionnaires) that enriches but does not duplicate the existing "glp1-atypical-anorexia-screening-gap-creates-invisible-high-risk-population.md" claim about the population gap; the enrichments add genuinely new evidence dimensions (DePaul JHLI mechanism, ANAD epistemic honesty, FDA warning letter regulatory gap, STAT News clinical risks) rather than restating existing evidence. ## 3. Confidence All three new claims are marked "experimental" which is appropriate given they rely on April 2026 DePaul JHLI analysis, March 2026 STAT News investigation, and FDA warning letters that represent emerging regulatory patterns rather than established clinical consensus or completed regulatory outcomes. ## 4. Wiki links Multiple wiki links reference claims like [[glp1-eating-disorder-screening-protocol-scoff-plus-history-plus-behavioral-assessment-recommended-for-pre-treatment-risk-stratification]], [[glp1-induced-gi-side-effects-reinforce-existing-purging-cycles-but-no-clinical-evidence-supports-de-novo-eating-disorder-induction]], [[glp1-eating-disorder-risk-doubles-with-prior-mental-health-history]], [[who-glp1-guideline-omits-eating-disorder-screening-despite-pharmacovigilance-signal]], and [[glp1-social-media-cosmetic-misuse-creates-eating-disorder-pathway]] that are not present in this PR and may be broken, but this is expected for an interconnected knowledge base with parallel development. ## 5. Source quality DePaul Journal of Health Law and Innovation (legal/policy analysis), STAT News (investigative health journalism with named sources), FDA warning letters (primary regulatory documents), ANAD guidance (professional society standards), and NPR Health reporting all represent credible sources appropriate for health policy and regulatory claims at experimental confidence. ## 6. Specificity The claim "algorithmic-telehealth-assessments-cannot-detect-complex-eating-disorder-presentations.md" makes a falsifiable architectural argument (questionnaires lack capacity for contextual clinical judgment); "glp1-telehealth-prescribing-scales-without-eating-disorder-screening-infrastructure.md" makes a falsifiable regulatory structure claim (FDA regulates marketing not prescribing criteria); "glp1-telehealth-warning-letters-target-concentrated-four-group-network.md" makes a falsifiable network concentration claim (30%+ of warned firms affiliate with four medical groups)—all could be disproven with contrary evidence about algorithmic capabilities, regulatory authority, or network structure. <!-- VERDICT:LEO:APPROVE -->